These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 678785)

  • 21. Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon.
    Sherwin RS; Bastl C; Finkelstein FO; Fisher M; Black H; Hendler R; Felig P
    J Clin Invest; 1976 Mar; 57(3):722-31. PubMed ID: 1249205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hematologic studies after experimental production of sustained uremia.
    Boral MC; Sherman JD
    Arch Pathol; 1969 May; 87(5):533-6. PubMed ID: 5776891
    [No Abstract]   [Full Text] [Related]  

  • 23. [The need for blood transfusions in intermittent hemodialysis].
    Hoier-Madsen K; Krogsgaard AR; Pedersen K
    Ugeskr Laeger; 1973 Oct; 135(40):2143-51. PubMed ID: 4789477
    [No Abstract]   [Full Text] [Related]  

  • 24. Association of advanced age with concentrations of uraemic toxins in CKD.
    Rroji M; Eloot S; Dhondt A; Van Biesen W; Glorieux G; Neirynck N; Vandennoortgate N; Liabeuf S; Massy Z; Vanholder R
    J Nephrol; 2016 Feb; 29(1):81-91. PubMed ID: 25857296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of erythropoietin therapy on the red cell volume of uraemic and non-uraemic rats.
    Anagnostou A; Barone J; Kedo A; Fried W
    Br J Haematol; 1977 Sep; 37(1):85-91. PubMed ID: 588481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of recombinant human erythropoietin (r-Hu EPO) administration on the blood chemistries and composition in uremic rats.
    Kozioł M; Ksiazek P; Feldo M; Spasiewicz D; Michalak J; Kleinrok Z
    Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():61-6. PubMed ID: 8192533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-invasive circulating indicators of bone metabolism in uraemic patients: can they replace bone biopsy?
    Schmidt-Gayk H; Drüeke T; Ritz E
    Nephrol Dial Transplant; 1996 Mar; 11(3):415-8. PubMed ID: 8671806
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma thrombomodulin concentrations in uraemic children.
    Ozdemir S; Beşbaş N; Saatçi U; Bakkaloğlu A
    Nephrol Dial Transplant; 1996 Nov; 11(11):2369-70. PubMed ID: 8941618
    [No Abstract]   [Full Text] [Related]  

  • 29. [pH-independent shifts of the oxygen-dissociation curve before and after hemodialysis].
    Weber R; Kleeberg U; Rühle K; Matthys H
    Schweiz Med Wochenschr; 1971 Dec; 101(49):1795-6. PubMed ID: 5140921
    [No Abstract]   [Full Text] [Related]  

  • 30. Impaired release of interleukin-6 from human osteoblastic cells in the uraemic milieu.
    Steddon SJ; McIntyre CW; Schroeder NJ; Burrin JM; Cunningham J
    Nephrol Dial Transplant; 2004 Dec; 19(12):3078-83. PubMed ID: 15494357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histidine supplementation for treatment of anaemia of uraemia.
    Blumenkrantz MJ; Shapiro DJ; Swendseid ME; Kopple JD
    Br Med J; 1975 Jun; 2(5970):530-3. PubMed ID: 1097035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma inhibitors of the erythrocyte hexose monophosphate shunt in uraemia.
    Zingraff J; Kamoun P; Lebreton P; Drüeke T; Man NK; Jungers P
    Proc Eur Dial Transplant Assoc; 1979; 16():475-80. PubMed ID: 548990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should hemoglobin be normalized in uremic patients?
    Foley RN
    Clin Nephrol; 2002 Jul; 58 Suppl 1():S58-61. PubMed ID: 12227728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The glycoregulatory response to glucagon and epinephrine infusions in chronic uremia].
    Perez G; Ungaro B; Morrone G; Covelli A; Usberti M; Dal Canton A; Andreucci VE
    Minerva Nefrol; 1979; 26(3):349-52. PubMed ID: 400449
    [No Abstract]   [Full Text] [Related]  

  • 35. Skin bleeding time for the evaluation of uremic platelet dysfunction and effect of dialysis.
    Soyoral YU; Demir C; Begenik H; Esen R; Kucukoglu ME; Aldemir MN; Demirkiran D; Erkoc R
    Clin Appl Thromb Hemost; 2012; 18(2):185-8. PubMed ID: 22327827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-adrenergic contribution to glucagon-induced glucose production and insulin secretion in uremia.
    Baylor P; Shilo S; Zonszein J; Shamoon H
    Am J Physiol; 1986 Sep; 251(3 Pt 1):E322-7. PubMed ID: 3019152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between hematocrit and erythrocyte magnesium concentration in patients on regular hemodialysis.
    Gonella M; Betti G; Buzzigoli G; Bartolini V
    Nephron; 1979; 24(3):134-7. PubMed ID: 492423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accumulation of uraemic toxins is reflected only partially by estimated GFR in paediatric patients with chronic kidney disease.
    Snauwaert E; Van Biesen W; Raes A; Holvoet E; Glorieux G; Van Hoeck K; Van Dyck M; Godefroid N; Vanholder R; Roels S; Walle JV; Eloot S
    Pediatr Nephrol; 2018 Feb; 33(2):315-323. PubMed ID: 28939943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coagulation abnormalities in diabetic patients undergoing renal transplantation.
    Reissell E; Lalla M; Höckerstedt K; Lindgren L
    Ann Chir Gynaecol; 1994; 83(3):251-5. PubMed ID: 7857071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperglucagonemia of renal failure.
    Bilbrey GL; Faloona GR; White MG; Knochel JP
    J Clin Invest; 1974 Mar; 53(3):841-7. PubMed ID: 4812442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.